Illuminating the breast cancer survival rates among Southeast Asian women: A systematic review and meta-analysis spanning four decades

IF 2.5 4区 医学 Q3 ONCOLOGY
Duc Tran Quang , Thanh Luong Thi , Khanh Nguyen Di , Chi Vu Thi Quynh , Huyen Nguyen Thi Hoa , Quang Phan Ngoc
{"title":"Illuminating the breast cancer survival rates among Southeast Asian women: A systematic review and meta-analysis spanning four decades","authors":"Duc Tran Quang ,&nbsp;Thanh Luong Thi ,&nbsp;Khanh Nguyen Di ,&nbsp;Chi Vu Thi Quynh ,&nbsp;Huyen Nguyen Thi Hoa ,&nbsp;Quang Phan Ngoc","doi":"10.1016/j.currproblcancer.2024.101062","DOIUrl":null,"url":null,"abstract":"<div><p>In Southeast Asia, breast cancer is the most prevalent cancer among women and ranks as the second leading cause of cancer-related deaths. This systematic review<span><span> and meta-analysis, encompassing 27 observational cohort studies with a minimum one-year follow-up period, aimed to examine temporal trends in breast cancer survival<span> rates. Among the subset of five out of eleven Southeast Asian nations with available data, our analysis revealed pooled survival rates of 88.8 % at 1 year, 73.8 % at 3 years, 70.8 % at 5 years, and 49.3 % at 10 years for breast cancer patients. The mean age at diagnosis was 50.77±10.07 years, with 52.81 % of patients presenting with positive lymph nodes. Notably, stages I and II remained predominant even five years post-diagnosis. Although an overall amelioration in survival rates transpired over the preceding four decades, a noticeable exception pertained to the 3-year rate, demonstrating limited improvement. These findings underscore the pressing need for enhanced research efforts, particularly in countries within the region that lack survival data, to enable accurate estimations. Furthermore, our review also emphasizes the crucial need for future comprehensive, well-designed studies to delve into the factors behind survival rate </span></span>disparities in Southeast Asia and the younger age at diagnosis compared to other regions.</span></p></div>","PeriodicalId":55193,"journal":{"name":"Current Problems in Cancer","volume":"48 ","pages":"Article 101062"},"PeriodicalIF":2.5000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Problems in Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0147027224000035","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In Southeast Asia, breast cancer is the most prevalent cancer among women and ranks as the second leading cause of cancer-related deaths. This systematic review and meta-analysis, encompassing 27 observational cohort studies with a minimum one-year follow-up period, aimed to examine temporal trends in breast cancer survival rates. Among the subset of five out of eleven Southeast Asian nations with available data, our analysis revealed pooled survival rates of 88.8 % at 1 year, 73.8 % at 3 years, 70.8 % at 5 years, and 49.3 % at 10 years for breast cancer patients. The mean age at diagnosis was 50.77±10.07 years, with 52.81 % of patients presenting with positive lymph nodes. Notably, stages I and II remained predominant even five years post-diagnosis. Although an overall amelioration in survival rates transpired over the preceding four decades, a noticeable exception pertained to the 3-year rate, demonstrating limited improvement. These findings underscore the pressing need for enhanced research efforts, particularly in countries within the region that lack survival data, to enable accurate estimations. Furthermore, our review also emphasizes the crucial need for future comprehensive, well-designed studies to delve into the factors behind survival rate disparities in Southeast Asia and the younger age at diagnosis compared to other regions.

阐明东南亚妇女的乳腺癌存活率:跨越四十年的系统回顾和荟萃分析
在东南亚,乳腺癌是女性中发病率最高的癌症,也是导致癌症相关死亡的第二大原因。这项系统性回顾和荟萃分析包括 27 项至少有一年随访期的观察性队列研究,旨在研究乳腺癌存活率的时间趋势。我们的分析显示,在东南亚 11 个国家中的 5 个国家中,有数据可查的乳腺癌患者 1 年生存率为 88.8%,3 年生存率为 73.8%,5 年生存率为 70.8%,10 年生存率为 49.3%。确诊时的平均年龄为(50.77±10.07)岁,52.81%的患者淋巴结呈阳性。值得注意的是,即使在确诊后五年,I 期和 II 期患者仍占多数。尽管在过去的四十年中,患者的存活率总体上有所提高,但三年存活率却明显例外,提高幅度有限。这些发现突出表明,迫切需要加强研究工作,特别是在该地区缺乏存活率数据的国家,以便做出准确的估计。此外,我们的综述还强调,今后亟需开展全面、精心设计的研究,以深入探讨东南亚地区存活率差异背后的因素,以及与其他地区相比,东南亚地区的诊断年龄更小的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Problems in Cancer
Current Problems in Cancer 医学-肿瘤学
CiteScore
5.10
自引率
0.00%
发文量
71
审稿时长
15 days
期刊介绍: Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal''s scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Papers that focus solely on laboratory-based or basic science research are discouraged. The journal''s format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信